Using AI towards new medical breakthroughs: Building the (virtual) cell

The quest to extend human healthspan and decode the biological mechanisms of aging is undergoing a profound transformation, driven by an inflection point in artificial intelligence. We are transitioning from a slow, observational approach in longevity science to a highly predictive, generative paradigm. I will explore how the convergence of advanced AI architectures and massive biological datasets is not just accelerating discovery, but fundamentally altering our approach to aging, cellular senescence, and age-related disease. At the foundation of this revolution are groundbreaking advances in biomolecular modeling and structural prediction. When coupled with emerging, purpose-built foundation models for biology and medicine, researchers are gaining the ability to decode intricate epigenetic and proteomic signatures. This enables the rational design of novel geroprotectors, targeted therapeutics, and highly personalized interventions with unprecedented speed and precision. However, the next frontier in longevity medicine lies in the transition from static structural mapping to dynamic biological simulation. The development of "world models" for biology and fully realized "virtual cells" represents a paradigm shift for the field. By simulating complex cellular behaviors and tissue-level interactions in silico, these dynamic models allow us to safely and rapidly test millions of potential anti-aging interventions. They enable researchers to predict complex systemic responses, model the long-term cascade of cellular aging, and evaluate multi-drug regimens without the immediate need for decades-long clinical trials.